In sum, hypoxia directly regulates ECM composition via multiple enzymes and, as such, P4HA1, P4HA2, PLOD2, and LOX enzymes could be used as biomarkers in breast cancer progression. The gene discussed is P4HA2; the disease is breast carcinoma.